ArticleEJNMMI research2025

Predicting pathological response to neoadjuvant chemoradiotherapy in resectable and borderline resectable pancreatic ductal adenocarcinoma: a comparative study of

Takashi Norikane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.